Skip to main content
Clinical Trials/NCT04696835
NCT04696835
Recruiting
Not Applicable

Use of Near-infrared Functional Spectroscopy (fNIRS) in the Evaluation of Hearing Rehabilitation in Children With Hearing Aid(s)

University Hospital, Lille1 site in 1 country40 target enrollmentSeptember 9, 2021
ConditionsHearing Loss

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hearing Loss
Sponsor
University Hospital, Lille
Enrollment
40
Locations
1
Primary Endpoint
Oxygenated haemoglobin concentration (HbO)
Status
Recruiting
Last Updated
4 months ago

Overview

Brief Summary

Pilot phase. Monocentric, non-controlled, non-randomized, open-label study evaluating the capacity of the functional near-infrared functional neuroimaging (fNIRS) technique to translate temporal cortical activity in response to a speech stimulus in normo-hearing and deaf children with cochlear implants.

Hemodynamic changes are expected to be observed that indicate brain activity following the stimuli, resulting in a change in the concentration of oxygenated hemoglobin (HbO) and deoxygenated hemoglobin (HbR) recorded by the fNIRS.

The use of the FNIRS in the evaluation of hearing aid effectiveness could contribute to a more adapted management of childhood hearing loss since conventional methods in young children are not adapted to the needs of children with hearing loss.

Registry
clinicaltrials.gov
Start Date
September 9, 2021
End Date
September 1, 2027
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Lille
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Group A: Infants and toddlers 3-18 months of age who are normal hearing.
  • Group B: Infants and toddlers aged 3 to 18 months with sensorineural hearing loss fitted with a unilateral or bilateral hearing aid with optimized adjustments by the hearing healthcare professional.
  • Socially insured subject
  • Parents or guardians who have given their consent to participate in the study

Exclusion Criteria

  • Medical condition that does not allow for research compliance.

Outcomes

Primary Outcomes

Oxygenated haemoglobin concentration (HbO)

Time Frame: Baseline (at inclusion)

Secondary Outcomes

  • HbR Concentration(At 3 months, 6 months, 12 months and 24 months)
  • Deoxygenated haemoglobin concentration (HbR)(Baseline (at inclusion))
  • HbO Concentration(At 3 months, 6 months, 12 months and 24 months)

Study Sites (1)

Loading locations...

Similar Trials